(Q38887019)

7 September 2017

1 reference

title

CBP/p300 acetyltransferase activity in hematologic malignancies (English)

1 reference

7 September 2017

Kathleen M Sakamoto

3

0 references

author name string

Ritika Dutta

series ordinal

1

1 reference

7 September 2017

Bruce Tiu

series ordinal

2

1 reference

7 September 2017

publication date

30 June 2016

1 reference

Molecular Genetics and Metabolism

7 September 2017

published in

1 reference

7 September 2017

volume

119

1 reference

7 September 2017

issue

1-2

1 reference

7 September 2017

page(s)

37-43

1 reference

Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Versatile molecular glue. Transcriptional control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

ZZ domain of CBP: an unusual zinc finger fold in a protein interaction module

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

p300 Transcriptional Repression Is Mediated by SUMO Modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

CBP and p300: HATs for different occasions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Transcription coactivators p300 and CBP are necessary for photoreceptor-specific chromatin organization and gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Drosophila CBP is a co-activator of cubitus interruptus in hedgehog signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Conjunction dysfunction: CBP/p300 in human disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Human p300 protein is a coactivator for the transcription factor MyoD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

CBP-independent activation of CREM and CREB by the LIM-only protein ACT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

CBP histone acetyltransferase activity regulates embryonic neural differentiation in the normal and Rubinstein-Taybi syndrome brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

CBP/p300 histone acetyl-transferase activity is important for the G1/S transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Recruitment of p300/CBP in p53-dependent signal pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Phosphorylated CREB binds specifically to the nuclear protein CBP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Chromatin modifications and their function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

The CBP co-activator is a histone acetyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

New nomenclature for chromatin-modifying enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

The structural basis of protein acetylation by the p300/CBP transcriptional coactivator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Differences in specificity and selectivity between CBP and p300 acetylation of histone H3 and H3/H4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Super-enhancers in the control of cell identity and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Selective inhibition of tumor oncogenes by disruption of super-enhancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Hallmarks of Cancer: The Next Generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Acetylation of cAMP-responsive element-binding protein (CREB) by CREB-binding protein enhances CREB-dependent transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

E2F Family Members Are Differentially Regulated by Reversible Acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

CREB-binding protein/p300 activates MyoD by acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Regulation of activity of the transcription factor GATA-1 by acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Structure and ligand of a histone acetyltransferase bromodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Structure and acetyl-lysine recognition of the bromodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Protein lysine acetylation by p300/CBP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Regulation of FoxO activity by CBP/p300-mediated acetylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Nerve growth factor up-regulates the transcriptional activity of CBP through activation of the p42/p44(MAPK) cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Phosphorylation by p44 MAP Kinase/ERK1 stimulates CBP histone acetyl transferase activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

The transcriptional co-activators CBP and p300 are activated via phenylephrine through the p42/p44 MAPK cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Nuclear protein CBP is a coactivator for the transcription factor CREB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

The transcriptional coactivator Cbp regulates self-renewal and differentiation in adult hematopoietic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Tumors in Rubinstein-Taybi syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Keloids and neoplasms in the Rubinstein-Taybi syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Rubinstein-Taybi syndrome: clinical and molecular overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Mutation and cancer: statistical study of retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Acetylation controls Notch3 stability and function in T-cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

CREBBP mutations in relapsed acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

MOZ and MOZ-CBP cooperate with NF-kappaB to activate transcription from NF-kappaB-dependent promoters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Monocytic leukemia zinc finger (MOZ) interacts with p53 to induce p21 expression and cell-cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Histone acetylation by p300 is involved in CREB-mediated transcription on chromatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

Acetylation control of the retinoblastoma tumour-suppressor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2016.06.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMGME.2016.06.013

1 reference

7 September 2017

1 reference